复合制剂的可接受性 - 罗马尼亚儿科医院的视角
Corina Briciu1, Daniel Leucuța2, Adina Popa1
1"Iuliu Hațieganu" University of Medicine and Pharmacy, Faculty of Pharmacy, Department of Clinical Pharmacy, Cluj-Napoca, Romania.
孩子 孩子 孩子 孩子
科学领域:
- 儿科药理学 儿科药理学
- 制药复合剂 制药复合剂
- 患者接受度研究 患者接受度研究
背景情况:
- 复合药物经常被处方给儿科患者.
- 了解孩子对这些制剂的接受对于治疗坚持至关重要.
- 关于罗马尼亚儿科环境中复合实践和可接受性的数据有限.
研究的目的:
- 评估罗马尼亚儿科患者中复合药物的可接受性.
- 确定影响可接受性的复合实践的特征.
- 为改善儿科药物守提供见解.
主要方法:
- 在三个儿科部门进行了观察性,横截面和回顾性研究.
- 包括使用复合药物的18岁以下患者.
- 通过面试官管理的调查问卷和面部快乐的三分标准来收集数据.
主要成果:
- 评估了162种复合药物.
- 可接受性因剂型而异:口服 (20.83%的阳性),口腔 (20.63%的阳性) 和皮肤 (66.67%的阳性).
- 尽管有一些不满,但在75%以上的病例中,药物管理成功.
结论:
- 诸如易于吞,囊形式和施用方法等因素会影响口服复合药物的可接受性.
- 提高复合制剂的可接受性是提高儿科治疗结果的关键.
- 这项研究为罗马尼亚儿科复合实践提供了有价值的数据.
更多相关视频
11:06Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care
Published on: November 11, 2022
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
相关概念视频
Factors Affecting Drug Response: Overview
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
Bioequivalence: Overview
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Two-Compartment Open Model: IV Bolus Administration
The disparity between drug input and the sum of drug transfer rates between...
